ATXI
AVENUE THERAPEUTICS INCstockOTC
EODNov 12, 2026
0.28USD-8.291%(-0.03)2,828
Loading…
Loading…
575,098
Healthcare
Biotechnology
HQ
Tampa, FL, USA
Previous Close
$0.31
Beta
1.01
52-Week High
$0.96 2025-12-02
52-Week Low
$0.15 2026-02-24
SMA 50
$0.43
SMA 200
$0.47
Avg. Vol 10D
2,793
Avg. Vol 30D
8,427
Avg. Vol 90D
6,006
Relative Vol
0.34
2.05M
2.85M
138.76%
0.00%
1.00
43.91%
32.53%
1
Apr 26, 2024 · 1-for-75 (reverse)
-2.8M
-159.97
ATXI Profile
avenue therapeutics, inc. (nasdaq: atxi), a fortress biotech (nasdaq: fbio) company, is a specialty pharmaceutical company focused on the development and commercialization of intravenous (iv) tramadol for the management of moderate to moderately severe postoperative pain. iv tramadol may fill a gap in the acute pain market between iv acetaminophen/nsaids and iv conventional narcotics. avenue is currently evaluating iv tramadol in a pivotal phase 3 program for the management of postoperative pain.
ATXI Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.31 | 2026-11-09 | -8.29% | 0.000 |
| 1M | 0.40 | 2026-10-20 | -30.73% | -1.368 |
| 3M | 0.26 | 2026-08-14 | +8.70% | 0.736 |
| 6M | 0.31 | 2026-05-18 | -9.62% | 0.577 |
| 1Y | 0.80 | 2025-11-17 | -65.00% | 1.006 |
| 2Y | 1.90 | 2024-11-18 | -85.26% | — |
| 5Y | 1,530.00 | 2021-11-17 | -99.98% | 0.006 |
ATXI Stock Summary
AVENUE THERAPEUTICS INC (OTC:ATXI) stock price today is $0.28, and today's volume is 2,828. ATXI is down 8.291% today. The 30 day average volume is 8,427. ATXI market cap is $575,098 with 2.05M shares outstanding.
